Gastrointestinal Cancer Program
MUSC Hollings Cancer Center is a national leader in the diagnosis and treatment of gastrointestinal malignancies, which include cancers of the esophagus, stomach, pancreas, liver, biliary tree, colon and rectum. The center works in close collaboration with the MUSC Digestive Disease Center, rated highly for many years for the treatment of gastrointestinal disorders by U.S. News & World Report.
South Carolina has the nation’s 14th highest death rate from esophageal cancer and 25th highest death rate for colorectal cancer, according to the National Cancer Institute. Our pancreatic cancer rates are among the highest in the nation. Fortunately, our research and clinical trials for gastrointestinal cancers, paired with recent advances in screening, diagnostics and treatment are helping to reverse these trends and replace them with hope for the future.
Multispecialty clinics staffed by medical, surgical and radiation oncologists, as well as gastroenterologists, are held for newly diagnosed patients. Complex cases are discussed by the appropriate specialists at weekly GI tumor board meetings. Even if patients aren’t seen by these doctors they get the advantage of their experience.
At MUSC Hollings Cancer Center, our Gastrointestinal Cancer Program focuses on:
- Colorectal Cancer (colon cancer & rectal cancer)
- Liver Cancer
- Pancreatic Cancer
- Stomach Cancer
- Esophageal Cancer